IIT-Roorkee Researchers Make Breakthrough In Cancer Therapy By Developing Fluorescent Carbon Nanodots
IIT-Roorkee Researchers Make Breakthrough In Cancer Therapy By  Developing Fluorescent Carbon Nanodots A view of IIT-Roorkee campus (Image via Wikimedia Commons)

Researchers from Indian Institute of Technology (IIT) Roorkee, have successfully developed fluorescent carbon nanodots that have the potential to serve as “theranostic” (therapeutic and diagnostic) agents for cancer, Economic Times has reported.

P Gopinath the team lead said that, “Such events of real-time image-guided anticancer therapy by a single system open a new paradigm in the field of anticancer therapy.”

The process of identifying cancer cells and the methods through which they can be inhibited have always stood like a challenge in the field of oncology and cancer drug research for many decades. However, in the past few years, nanotechnology has emerged as one of the most promising options in cancer diagnostics, treatment and nanomaterials.

The team of IIT Roorkee researchers led by P Gopinath have successfully developed nanosized carbon materials which have been extracted from the leaves of the rosy periwinkle plant. This project has been supported by the Science and Engineering Research Board and Department of Biotechnology.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement